The stock settled the day with a sharp gain of 8.34 per cent at Rs 1,168.50 on the BSE. In intra-day, it rallied 9.4 per cent to Rs 1,180 -...

Under the terms of the agreement, the company's subsidiary is entitled to launch its version of generic Angiomax in the US on June 30, 2019.

Indian firm Aurobindo Pharma has been dragged to court by three multi-national drug makers on allegations of patent infringement.